AsiaNet 84071

OBERKOCHEN, Germany, May 19, 2020 /PRNewswire=KYODO JBN/ --

- Half-year revenue reaches 3.2 billion euros (+6% compared to prior year) –

EBIT at 455 million euros (+12 million euros compared to prior year)

- The Semiconductor Manufacturing Technology and Medical Technology segments

contributed in particular to growth in the first six months

- Initial impact of the COVID-19 pandemic felt particularly in Q2

- ZEISS portfolio ensures stability even during the COVID-19 pandemic

- Difficult to form outlook on further progression of fiscal year

Overall, the first six months of fiscal year 2019/20 (ended 31 March 2020) went

well for the ZEISS Group. It saw its revenue rise by 6 percent (compared to 3

percent) to EUR 3.213 billion (first six months of 2018/19: EUR 3.019 billion).

90 percent of this sum was generated by markets outside Germany. At EUR 455

million, earnings before interest and tax (EBIT) were slightly higher than the

previous year (EUR 443 million). The EBIT margin was at 14.2%. Incoming orders

hit EUR 3.601 billion (1st six months of 2018/19: EUR 3.161 billion).

"Overall, we were successful during the first half of the fiscal year. However,

the COVID-19 pandemic has had a major impact on the global economy – including

on ZEISS' lines of business," said Dr. Karl Lamprecht, ZEISS President and CEO.

He continued: "ZEISS' resilience measures will help it combat the current

challenges in the best possible way."

At this time it is not possible to make a reliable prediction for the 2019/20

fiscal year due to the global uncertainty surrounding the COVID-19 pandemic.

Please visit

https://www.zeiss.com/corporate/int/newsroom/press-releases/2020/zeiss-half-year-figures-2019-20.html

for full text version.

Contact for the press:

ZEISS Group

Jörg Nitschke

Head of Corporate Brand and Communications

Tel.: +49-(0)7364-20-3242

Email: joerg.nitschke@zeiss.com

www.zeiss.com/newsroom

Source: Carl Zeiss AG